Real-world Study on Bemiparin Effect in Patients with Cancer-Associated Thromboembolism Using Artificial Intelligence (BEMICAT Study)

ENCePP Code of conduct

N/A

Data sources

• Data source(s):
  Other data source
• Data source(s), other:
  Electronic Health Records from study sites
• Data sources (types):
  Drug prescriptions

  Drug registry

  Electronic healthcare records (EHR)

  Laboratory tests and analyses

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Not applicable

Procedures

Procedure of data extraction

ROVI_BEMICAT_Protocol_V1.1_27FEB2025_data extraction.pdf